Cargo Therapeutics discontinued a study evaluating firicabtagene autoleucel, an autologous CD22 chimeric antigen receptor (CAR) T-cell therapy for large B-cell lymphoma and the company’s lead ...
At today’s Senate Health, Education, Labor, and Pensions Committee hearing, nominee for Secretary of the Department of Health and Human Services Robert F. Kennedy (RKF) Jr. refused to renounce his ...
Main Finding: A phase I trial supported the safety and feasibility of repeated intracranial infusions of B7-H3 CAR T cells for DIPG. Concept: B7-H3 is an immunoregulatory protein expressed on the ...
1The University of Texas MD Anderson Cancer Center, Houston, TX. Search for other works by this author on: ...
1The Nairobi Hospital, Nairobi, Kenya.
Search for other works by this author on: ...
1Geman Cancer Research Center DKFZ, Heidelberg, Germany.
1Stanford University, Stanford, CA.
Search for other works by this author on: ...
1Stanford University, Stanford, CA.
This open access article is distributed under the Creative Commons Attribution 4.0 International (CC BY 4.0) license.
Major Finding: IL-33 drives the formation of tertiary lymphoid structures in inflammation and pancreatic cancer. Concept: IL-33 activates gut-derived group 2 innate lymphoid cells to induce tertiary ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback